Metraipolis › archive › dc_026e69137ec5
Immune checkpoint inhibitors in infectious diseases: therapeutic reinvigoration, immunopathology, and precision targeting — Europe PMC PMID:42614304
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42614304
- DOI
- 10.3389/fimmu.2026.1894437
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-17T05:13:33.670Z
- SHA-256 of the archived text
1c624459088baad68f4ba7f4602b057cf300dd751f72d23911fc8dd05617214f- Stable URL of this page
https://metraipolis.com/documento/dc_026e69137ec5
How to cite
Immune checkpoint inhibitors in infectious diseases: therapeutic reinvigoration, immunopathology, and precision targeting — Europe PMC PMID:42614304 — Europe PMC (en), https://europepmc.org/article/MED/42614304 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_026e69137ec5 (Metraipolis archive dc_026e69137ec5, sha256 1c624459088baad68f4ba7f4602b057cf300dd751f72d23911fc8dd05617214f)
BibTeX
@misc{dc026e69137ec5,
title = {Immune checkpoint inhibitors in infectious diseases: therapeutic reinvigoration, immunopathology, and precision targeting — Europe PMC PMID:42614304},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42614304},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_026e69137ec5; sha256 1c624459088baad68f4ba7f4602b057cf300dd751f72d23911fc8dd05617214f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42614304. Agents can read the archived copy with the MCP tool read_document.